Entourage’s Post

On the 24th and 25th April, we had the pleasure of hosting our annual face-to-face MidPharma R&D Symposium in London, the first since the COVID-19 pandemic. The event began with a networking dinner on the evening of the 24th followed by facilitated discussions on the 25th. The symposium was attended by 13 R&D Leaders from 9 European-headquartered MidPharmas. We facilitated sub-group discussions on how to enhance R&D productivity, with a focus on: - Enhancing productivity of the project-function matrix - Optimising decision-making and capabilities - Blending external and internal innovation From our lively and fascinating Chatham House Rule discussions, it was clear that MidPharmas which pilot or implement new ways to address R&D challenges are those that have the best chance of success. Simply living with challenges is not an option. We are already looking forward to hosting our R&D symposium next year. Please contact John Rountree, Andrew Bell or John Gregson for more information or to request an invitation. #ResearchandDevelopment #Novasecta #MidPharmas #Pharma #Pharmaceuticals #Biopharma #Symposium #RandDProductivity

In the fast-paced world of pharmaceuticals, #collaboration is key to achieving groundbreaking innovations and reaching new horizons. If you're a part of the international #pharmaceutical community, here are two compelling reasons why you should consider collaborating #venuspharma at the upcoming #CPHI. 📣 A Proven Track Record of Success:  Venus Pharma has a track record that speaks for itself. Our commitment to excellence and dedication to the pharmaceutical industry have led to remarkable achievements. By collaborating with us, you'll be joining forces with a team that knows how to turn combined efforts into dividends. 🌍 Ambitions for #emea: If you're looking to tap into new markets /Newer products or explore international partnerships, collaborating with Venus Pharma can be your gateway to a world of opportunities. Don't miss the chance to be part of this dynamic and forward-thinking collaboration for Hospital portfolio enhancement especially in #oncology #carbapenem #cephalosporin segment. 🧡🧡 Dans l'attente d'avoir des partenaires de licence, de distribution et de marketing en #France pour notre gamme de produits antibactériens et oncologiques. 🧡🧡🧡 Esperamos contar con socios de licencia, distribución y marketing de #España para nuestra gama de productos antibacterianos y oncológicos. 🙋♂️ Connect with me for your #CDMO #licensing #sitetransfer requirements. We also offer EU release services , Secondary packaging , Warehousing service from our German site. #VishalChandra 📧 : vc@venuspharmagmbh.de THANK YOU :- Our existing partners #cnx #jed #teva #tillomed #thrive #medilink #pontus #antibiotice #targethealthcare #ascot #pharmacenter #ligula #scalapharma #qualimetrix #gdmedical #corapharma #unifarma #lagap #dafra #pharmamatch

📅 Save the Date: Join LifeSci Events and Reneo Pharmaceuticals for a live and virtual KOL event on October 9th at 12:00 PM EDT! Reserve your seat: https://lnkd.in/eECnfbgR 🌟 Featured Key Opinion Leader: – Amel Karaa, MD (Massachusetts General Hospital), PI of the STRIDE Study Join us for a valuable conversation about the existing medical gaps and current treatments for patients with primary mitochondrial myopathies (PMM). The Reneo team will shed light on the STRIDE study, a worldwide, randomized, double-blind, half-year, placebo-controlled clinical trial evaluating the effectiveness and safety of orally administered mavodelpar for adult PMM patients with mitochondrial DNA defects. Anticipate top-line data in the last quarter of 2023. 🎤 Live Q&A: A live question and answer session will follow the formal presentation! #PMM #Pharma #Pharmaceuticals #LifeSciEvent #LifeSciences

In the latest edition of NPC Healthbiz Weekly, a publication of the National Pharmaceutical Congress, we dive into a topic that's reshaping the landscape of the life sciences industry: #Biosimilars. Will this phenomenon be a game-changer for #lifesciences, or does it harken back to the generics wars of the 1990s? As we navigate this evolving landscape, we must consider the potential impact on patient access, innovation, and market dynamics. NPC Healthbiz Weekly, created by Chronicle Companies with support from Impres, is committed to providing you with comprehensive #insights into the ever-changing healthcare industry. Subscribe at https://lnkd.in/egugfuE and never miss an issue. #pharma #leadership https://lnkd.in/gD4T_BgJ

#covid, #covid19, #coronavirus, #pirola, #omicron, #covid19pandemic, #covid19impact, #covidinquiry, #covidimpact, #covid19response, #covid19research Please sign the petition I started asking the UK Covid Inquiry to determine the most appropriate duration for non-pharmaceutical interventions (NPIs) to be applied using the most accurate model https://chng.it/6LdCjRzySp. I can run simulations showing the result of modifications to duration that non-pharmaceutical interventions are applied to achieve better outcomes. The Inquiry is beginning Module 2 looking at NPIs, so there is considerable urgency if the best available evidence is to be considered.

CQDM. We celebrate. 15th anniversary of CQDM. 2018: Creation of CATALIS After starting the initiative and hosting the CATALIS structure, the CQDM, in 2018, created the neutral and independent entity CATALIS Québec which holds the government mandate to optimize the clinical research environment in Quebec in collaboration with the various life sciences players to accelerate the development of innovative treatments for the benefit of patients. Since its creation, CATALIS has continued to expand its Network, which today has nearly 70 public-private partners, including 23 establishments in the health and social services network, as well as 15 pharmaceutical companies. Among CATALIS' major achievements is the FAST TRACK Evaluation Service, which aims to authorize clinical trials in 8 weeks, a reduction of almost 75% of the global standard authorization time. This Service has already enabled several health establishments in Quebec to be the first activated sites in the world, thus positioning Quebec on the global stage of clinical research. “I would like to thank Diane Gosselin, CEO of CQDM, for her commitment and great contribution to the CATALIS mission, as well as for her role as executive president of the CATALIS board of directors from 2017 to 2020. I am proud to note the path traveled by CATALIS thanks to the strength of our collaborations. I will continue to leverage the know-how of our entire team and mobilize our large network of partners, to ensure the success of our mission and the growth of our organization. » declared Danika Laberge, CEO of CATALIS Québec. More info: https://lnkd.in/esdAJAgt.. #lifesciences #biotechnology #drugdevelopment #innovation #funding #projects #medical #research #intelligenceartificielle #artificialintelligence #pharmaceutique #pharmaceutical #biopharma #biopharmaceutical #rna #rnatherapeutics #arn #faciliterinnovationbiopharma #anniversaire #anniversary

https://lnkd.in/dNKk6b2G Key Insights: • The partnership unites Gilead's established history and commitment to creating groundbreaking therapies for severe viral illnesses with Assembly Bio's specialized knowledge and dedication to antiviral research and development. Together, they aim to progress innovative treatments for herpesviruses, HBV, HDV, and more • According to the agreement, Assembly Bio will be granted $100 million, which includes an initial payment of $84.8 million and a $15.2 million investment in equity by Gilead Visit MedicoInsights to explore key insights #HealthcareNews #drugs #StayInformed #MedicalNews #drugapproval #HealthTrends #Insights #HealthIndustry #HealthInnovation #gilead #collaboration #partership #HealthcareAnalytics #NewsUpdate #news #HealthcareNetworking #pharma #pharmaceuticals #pharmanews #pharmaindustry #pharmainnovation #update #medicoinsights

CPHI Barcelona is less than a week away ⏰🛫   Neucin’s Gavin Kovacs and Carol Balfour will be attending next week, so if you are attending and would like to meet in person, have a chat over a coffee☕️and discover how we help our clients with their drug delivery device design and development requirements then just send us a message via LinkedIn or email us on the email address below 👇 info@neucindesign.com ➡️ For more information about CPHI Barcelona, visit 👉 https://lnkd.in/dFwqjzvM    Were looking forward to some great discussions and hope to catch-up with some familiar faces, friends and partners across the event. See you all in Barcelona! #medicaldevices #innovation #design #engineering #research #technology #medtech #researchanddevelopment #productdesign #productdevelopment #development #drugdelivery #nasal #pharma #pharmaceuticals #diagnostics #devices #healthtech #healthtechnology #innovationinhealthcare #respiratory #inhalation #inhaler #DPI #MDI #SMI #nebuliser #oindp #pharmaceuticals #formulation #respiratory #pulmonary #networkingopportunities #CPHI #CPHIBCN #event #exhibitions #conferences #projects #acceleratedevelopment #neucin #neucininnovates

Barcelona, Such a beautiful horizon! 😉 Let’s put the finishing touches and make sure everything is ready for you: tomorrow, CPHI opens at 9am! Come over at booth #3S74 - we’ve got some news! #CPhI #CPhIbarcelona #CPhI2023 #CPhIWW #TemaSinergie #biopharma #asepticmanufacturing #biotecnologia #testsystems #asepticprocessing #pharmaceuticalmanufacturing #pharmaceuticalindustry #biomedicalengineering #pharmacist #pharma #pharmacy #qa #sterility #sterilitytesting #isolators #integrity #testing

"Miracles are a daily occurrence, reminding us that the extraordinary can happen in the most unexpected moments. Moreover, we hold the power to become those very miracles that reshape the world. It's essential to keep in mind that monumental transformations often stem from the tiniest yet most profound miracles." #togetherwewin #togetherisbetter #biotechnologyindustry #biopharmaceuticals #family #4to5 #analyticalchemistry #analyticaldevelopment #4i #wecanhelp